102
Views
3
CrossRef citations to date
0
Altmetric
Original Research

The association between neutrophil to lymphocyte ratio and endothelial dysfunction in people living with HIV on stable antiretroviral therapy

, , , ORCID Icon, , , , ORCID Icon & show all
Pages 113-120 | Received 25 Feb 2021, Accepted 19 May 2021, Published online: 01 Jun 2021

References

  • Bäck M, Yurdagul A Jr, Tabas I, et al. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389–406.
  • Abdolmaleki F, Gheibi Hayat SM, Bianconi V, et al. Atherosclerosis and immunity: a perspective. Trends Cardiovasc Med. 2019;29(6):363–371.
  • Schillaci G, Pirro M. C-reactive protein in hypertension: clinical significance and predictive value. Nutr Metab Cardiovasc Dis. 2006;16(7):500–508.
  • Subramanian S, Tawakol A, Burdo TH, et al. Arterial inflammation in patients with HIV. JAMA. 2012;308(4):379–386.
  • Nou E, Lo J, Grinspoon SK. Inflammation, immune activation, and cardiovascular disease in HIV. AIDS. 2016;30(10):1495–1509.
  • Ross AC, Rizk N, O’Riordan MA, et al. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis. 2009;49(7):1119–1127.
  • Ross AC, O’Riordan MA, Storer N, et al. Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children. Atherosclerosis. 2010;211(2):492–498.
  • Subramanya V, McKay HS, Brusca RM, et al. Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the multicenter AIDS cohort study. PLoS One. 2019;14(4):e0214735.
  • Dirajlal-Fargo S, Yu J, Albar Z, et al. Monocyte activation and gut barrier dysfunction in South African youth on antiretroviral therapy and their associations with endothelial dysfunction. AIDS. 2020;34(11):1615–1623.
  • Temu TM, Polyak SJ, Zifodya JS, et al., Endothelial dysfunction is related to monocyte activation in antiretroviral-treated people with HIV and HIV-negative adults in Kenya. Open Forum Infect Dis. 7(10): ofaa425. 2020.
  • Hsue PY, Hunt PW, Schnell A, et al., Inflammation is associated with endothelial dysfunction among individuals with treated and suppressed HIV infection. J Am Coll Cardiol. 55(10): A168.E1577. 2010.
  • Bhat T, Teli S, Rijal J, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013;11(1):55–59.
  • Angkananard T, Anothaisintawee T, McEvoy M, et al. Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:2703518.
  • Castanheira FVS, Kubes P. Neutrophils and NETs in modulating acute and chronic inflammation. Blood. 2019;133(20):2178–2185.
  • Piccirillo CA. Regulatory T cells in health and disease. Cytokine. 2008;43(3):395–401.
  • Moore DK, Loxton AG. Regulatory B lymphocytes: development and modulation of the host immune response during disease. Immunotherapy. 2019;11(8):691–704.
  • Li Y, Chen X, Huang L, et al. Association between neutrophil-lymphocyte ratio and arterial stiffness in patients with acute coronary syndrome. Biosci Rep. 2019;39(5):BSR20190015.
  • Suárez-Cuenca JA, Ruíz-Hernández AS, Mendoza-Castañeda AA, et al. Neutrophil-to-lymphocyte ratio and its relation with pro-inflammatory mediators, visceral adiposity and carotid intima-media thickness in population with obesity. Eur J Clin Invest. 2019;49(5):e13085.
  • Nam SH, Kang SG, Song SW. The neutrophil-lymphocyte ratio is associated with coronary artery calcification in asymptomatic korean males: a cross-sectional study. Biomed Res Int. 2017;2017:1989417.
  • Martínez-Urbistondo D, Beltrán A, Beloqui O, et al. The neutrophil-to-lymphocyte ratio as a marker of systemic endothelial dysfunction in asymptomatic subjects. Nefrologia. 2016;36(4):397–403.
  • Solak Y, Yilmaz MI, Sonmez A, et al. Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease. Clin Exp Nephrol. 2013;17(4):532–540.
  • Ortega-Zaragoza NY, Bollo-Pazos JC, Alvarez-Mendoza JP, et al. P5337 Neutrophil-lymphocyte ratio and peripheral arterial disease in HIV infection. Eur Heart J. 2019;40(Supplement 1).
  • Quiros-Roldan E, Raffetti E, Donato F, et al., Neutrophil to lymphocyte ratio and cardiovascular disease incidence in HIV-infected patients: a population-based cohort study. PLoS One. 11(5): e0154900. 2016.
  • Hanberg JS, Freiberg MS, Goetz MB, et al. VACS project team. neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic inflammatory biomarkers in Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and HIV/HCV coinfection. Open Forum Infect Dis. 2019;6(10):ofz347.
  • Pirro M, Mannarino MR, Francisci D, et al. Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy. Sci Rep. 2016;6(1):28741.
  • Pirro M, Schillaci G, Romagno PF, et al. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function. J Cardiovasc Pharmacol Ther. 2009;14(1):14–21.
  • Marwick JA, Mills R, Kay O, et al. Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-κB activation. Cell Death Dis. 2018;9(6):665.
  • Rosales C. Neutrophil: a Cell with Many Roles in Inflammation or Several Cell Types? Front Physiol. 2018;9:113.
  • Luckheeram RV, Zhou R, Verma AD, et al. CD4⁺T cells: differentiation and functions. Clin Dev Immunol. 2012;2012:925135.
  • Chevalier MF, Weiss L. The split personality of regulatory T cells in HIV infection. Blood. 2013;121(1):29–37.
  • Levine AM, Karim R, Mack W, et al. Neutropenia in human immunodeficiency virus infection: data from the women’s interagency HIV study. Arch Intern Med. 2006;166(4):405–410.
  • Margolis AM, Heverling H, Pham PA, et al. A review of the toxicity of HIV medications. J Med Toxicol. 2014;10(1):26–39.
  • Shi X, Sims MD, Hanna MM, et al. Neutropenia during HIV infection: adverse consequences and remedies. Int Rev Immunol. 2014;33(6):511–536.
  • Ma Y, Yang X, Chatterjee V, et al. Role of neutrophil extracellular traps and vesicles in regulating vascular endothelial permeability. Front Immunol. 2019;10:1037.
  • Drechsler M, Megens RT, Van Zandvoort M, et al. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation. 2010;122(18):1837–1845.
  • Dinerman JL, Mehta JL, Saldeen TG, et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol. 1990;15(7):1559–1563.
  • Kassan M, Wecker A, Kadowitz P, et al. CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension. J Hypertens. 2013;31(10):1939–1943.
  • Tamosiuniene R, Tian W, Dhillon G, et al. Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension. Circ Res. 2011;109(8):867–879.
  • Meng X, Yang J, Dong M, et al. Regulatory T cells in cardiovascular diseases. Nat Rev Cardiol. 2016;13(3):167–179.
  • Kusnadi D, Liwang MNI, Katu S, et al. Correlation between the neutrophil-to-lymphocyte count ratio and bacterial infection in patient with human immunodeficiency virus. IPO Conf Ser: Earth Environ Sci. 2018;125:012029.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.